English (United States)


Pathology : Oncology / Cancer
reduce font Size enlarge font Size print content

Study Title

Relevance of suppressor of cytokine signaling proteins (SOCS) for the molecular pathogenesis of colorectal carcinoma.

Study Detail

Study Objective


  • Determine if methylated SOCS promotor regions can be used as markers for colon carcinoma.
  • Determine if dysregulated feedback inhibition of cytokine/growth factor signalling via SOCS proteins does contribute to the molecular pathogenesis of colorectal carcinoma


Participation conditions

Inclusion criteria:


  • Patients with a suspected or confirmed diagnosis of colorectal cancer or scheduled for surgical resection of their primary tumor and / or metastases.


Exclusion criteria:

  • Pregnant women
  • Minors (subjects less than 18 years of age)
  • Prisoners
  • Subjects unable to consent



Contact person

Jérôme Graas, Research Nurse
(+352) 26970-808

Tags: IBBL, oncology, cancer, colon, colorectal, tumor, carcinoma, SOCS

Studies overview

This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.